Akorn Offloads Consumer Health For $230m
All-Cash Deal Allows Beleaguered Firm To Invest In Optimizing Prescription Business
Akorn has announced a $230m all-cash deal to divest its consumer healthcare business to Prestige Consumer Healthcare. The transaction will allow Akorn – which recently went through bankruptcy proceedings – to invest in optimizing its prescription business.
